131 related articles for article (PubMed ID: 10235068)
1. Vinorelbine in the treatment of lymphoma.
Rule S; Tighe M; Davies S; Johnson S
Hematol Oncol; 1998 Sep; 16(3):101-5. PubMed ID: 10235068
[TBL] [Abstract][Full Text] [Related]
2. Activity of single agent vinorelbine in pretreated non-Hodgkin's lymphoma.
Balzarotti M; Santoro A; Tondini C; Fornier M; Bonadonna G
Ann Oncol; 1996 Nov; 7(9):970-2. PubMed ID: 9006750
[TBL] [Abstract][Full Text] [Related]
3. Promising long-term outcome of gemcitabine, vinorelbine, liposomal doxorubicin (GVD) in 14-day schedule as salvage regimen for patients with previously heavily treated Hodgkin's lymphoma and aggressive non-Hodgkin's lymphoma.
Bai B; Huang HQ; Cai QQ; Wang XX; Cai QC; Lin ZX; Gao Y; Xia Y; Bu Q; Guo Y
Med Oncol; 2013 Mar; 30(1):350. PubMed ID: 23329307
[TBL] [Abstract][Full Text] [Related]
4. Vinorelbine (Navelbine), cisplatin, and concomitant radiation therapy for advanced malignancies of the chest: a Phase I study.
Vokes EE; Haraf DJ; Masters GA; Hoffman PC; Drinkard LC; Ferguson M; Olak J; Watson S; Golomb HM
Semin Oncol; 1996 Apr; 23(2 Suppl 5):48-52. PubMed ID: 8610237
[TBL] [Abstract][Full Text] [Related]
5. Vinorelbine: a new promising drug in Hodgkin's disease.
Devizzi L; Santoro A; Bonfante V; Viviani S; Bonadonna G
Leuk Lymphoma; 1996 Aug; 22(5-6):409-14. PubMed ID: 8882953
[TBL] [Abstract][Full Text] [Related]
6. Preliminary report on a phase I study of ifosfamide and vinorelbine (navelbine) in advanced non-small cell lung cancer.
Masters GA; Hoffman PC; Drinkard LC; Watson S; Samuels BL; Golomb HM; Vokes EE
Semin Oncol; 1996 Apr; 23(2 Suppl 5):11-8. PubMed ID: 8610230
[TBL] [Abstract][Full Text] [Related]
7. Infusional vinorelbine in relapsed or refractory lymphomas.
Sarris AH; Psyrri A; Hagemeister F; Romaguera J; McLaughlin P; Rodriguez MA; Bachier C; Younes A; Mesina O; Oholendt M; Medeiros LJ; Samuels B; Adams LM; Cabanillas F
Leuk Lymphoma; 2000 Oct; 39(3-4):291-9. PubMed ID: 11342309
[TBL] [Abstract][Full Text] [Related]
8. The current and future place of vinorelbine in cancer therapy.
Cvitkovic E; Izzo J
Drugs; 1992; 44 Suppl 4():36-45; discussion 66-9. PubMed ID: 1283849
[TBL] [Abstract][Full Text] [Related]
9. Update: vinorelbine (navelbine) in non-small cell lung cancer.
Crawford J
Semin Oncol; 1996 Apr; 23(2 Suppl 5):2-7. PubMed ID: 8610232
[TBL] [Abstract][Full Text] [Related]
10. Inability to escalate vinorelbine dose intensity using a daily x3 schedule with and without filgrastim in patients with metastatic breast cancer.
Havlin KA; Ramirez MJ; Legler CM; Harris LN; Matulonis UA; Hohneker JA; Hayes DF; Winer EP
Cancer Chemother Pharmacol; 1999; 43(1):68-72. PubMed ID: 9923543
[TBL] [Abstract][Full Text] [Related]
11. Vinorelbine and gemcitabine as salvage treatment in advanced and very poor prognosis non-Hodgkin's lymphoma patients.
Perrotti AP; Niscola P; Tendas A; Scaramucci L; Palombi M; Cupelli L; Dentamaro T; Piccioni D; Giovannini M; de Fabritis P
Ann Hematol; 2008 Jun; 87(6):493-4. PubMed ID: 18074132
[No Abstract] [Full Text] [Related]
12. Vinorelbine tartrate (Navelbine): drug profile and nursing implications of a new vinca alkaloid.
Brogden JM; Nevidjon B
Oncol Nurs Forum; 1995 May; 22(4):635-46. PubMed ID: 7675666
[TBL] [Abstract][Full Text] [Related]
13. Paclitaxel in the salvage treatment of Hodgkin's disease and non-Hodgkin's lymphoma.
Hopfinger G; Heinz R; Pfeilstöcker M; Schlögl E; Waldner R; Pittermann E
Ann Oncol; 1996 Apr; 7(4):423-4. PubMed ID: 8805938
[No Abstract] [Full Text] [Related]
14. Vinorelbine (Navelbine). A new semisynthetic vinca alkaloid.
Krikorian A; Breillout F
Onkologie; 1991 Feb; 14(1):7-12. PubMed ID: 2057177
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of weekly i.v. vinorelbine as a single agent in first-line advanced breast cancer chemotherapy. The Latin-American experience.
Bruno S; Puerto VL; Mickiewicz E; Hegg R; Texeira LC; Gaitan L; Martinez L; Fernandez O; Otero J; Kesselring G
Am J Clin Oncol; 1995 Oct; 18(5):392-6. PubMed ID: 7572754
[TBL] [Abstract][Full Text] [Related]
16. Treatment of vinorelbine-associated tumor pain.
Long TD; Twillman RK; Cathers-Schiffman TA; O'Donnell T
Am J Clin Oncol; 2001 Aug; 24(4):414-5. PubMed ID: 11474276
[TBL] [Abstract][Full Text] [Related]
17. Vinorelbine (Navelbine)/carboplatin combination therapy: dose intensification with granulocyte colony-stimulating factor.
Crawford J; O'Rourke MA
Semin Oncol; 1994 Oct; 21(5 Suppl 10):73-8. PubMed ID: 7526467
[TBL] [Abstract][Full Text] [Related]
18. Vinorelbine and prednisone in frail elderly patients with intermediate-high grade non-Hodgkin's lymphomas.
Tirelli U; Balzarotti M; Uziel L; Ferreri AJ; Santoro A; Spina M
Ann Oncol; 2006 Mar; 17(3):533. PubMed ID: 16291585
[No Abstract] [Full Text] [Related]
19. A phase II study of cisplatin, 5-fluorouracil, and leucovorin augmented by vinorelbine (Navelbine) for advanced non-small cell lung cancer: rationale and study design.
Vokes EE; Drinkard LC; Samuels BL; Hoffman PC; Watson S; Bitran JD; Haraf DJ; Ferguson MF; Golomb HM
Semin Oncol; 1994 Oct; 21(5 Suppl 10):79-83; discussion 83-4. PubMed ID: 7973772
[TBL] [Abstract][Full Text] [Related]
20. Summary of data from in vitro and phase I vinorelbine (Navelbine) studies.
Burris HA; Fields S
Semin Oncol; 1994 Oct; 21(5 Suppl 10):14-9; discussion 19-20. PubMed ID: 7973764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]